SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dick's Sporting Goods, Inc. engages in the retailing of an extensive assortment of authentic sports equipment, apparel, footwear, and accessories. It also offers its products both online and through mobile applications. The company was founded by Richard T. Stack in 1948 and is headquartered in Coraopolis, PA.

Dicks Sporting Goods, Inc.

DKS shares are getting slammed after a brutal Q2 earnings miss and steep full-year guidance cut, amplifying fears tied to the Foot Locker acquisition and a deteriorating athletic footwear market. Traders are fiercely split, with many dismissing the ~30% crash as an extreme overreaction and an oversold entry point, while others warn of a falling knife as analysts slash price targets and question the company's strategic direction.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

RIGL is surging as investors react to the company's exclusive global licensing agreement for VEPPANU, the first FDA-approved PROTAC therapy for breast cancer, which analysts and shareholders view as a major growth catalyst that could transform the company's commercial portfolio. The buzz centers on the drug's large market potential and the belief that the stock is significantly undervalued, with retail traders pointing to high short interest as fuel for a potential squeeze.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

SMMT is trending as investors weigh the recent NMPA approval for ivonescimab in China against a $500M dilutive offering and the looming FDA PDUFA on Nov 14, while CEO insider buying and positive phase 3 data keep bulls optimistic and bears questioning Western efficacy and the FDA's OS bar.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending as the biotech community debates its FDA-approved IgAN drug Trutakna, with discussions centered on competitive positioning against Otsuka's rival therapy, persistent short interest, and speculation over a potential buyout or upcoming clinical data. Community sentiment remains divided between concerns about competition and conviction in the drug's efficacy and the company's undervaluation.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne is trending as the community highlights a wave of bullish analyst price target raises into earnings, which are expected to deliver a beat-and-raise. The narrative focuses on its valuation gap versus peers like CrowdStrike and constant speculation about a potential big-tech acquisition or strategic partnership.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

CRML is surging with the rare-earth sector as U.S. government funding for critical minerals and progress at its Tanbreez project drive a wave of bullish retail sentiment, with traders eyeing a potential short squeeze.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

IMMX is trending on anticipation of its upcoming NXC-201 topline data, with traders highlighting high short interest, potential buyout scenarios, and bullish analyst coverage. Community sentiment is overwhelmingly optimistic, citing the drug's breakthrough therapy status and the potential for a short squeeze.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Traders are focused on Uber's push toward a key resistance level, with bullish sentiment tied to its expanding autonomous-vehicle partnerships, analyst support, and improving free-cash-flow generation. The broader debate centers on Uber's role in the robotaxi race against Waymo and Tesla, while a Dutch GDPR fine and driver complaints remain lingering concerns.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

CSIQ is trending as retail traders anticipate an imminent earnings report, framing it as a potential catalyst for a short squeeze given a large reported short interest, and contrasting the stock's valuation against a subsidiary's market cap. The community is also actively discussing alleged market manipulation and the potential for catalysts like 45X tax credits and U.S. production ramp-up to re-rate the stock.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Investors are actively debating whether BULL's recent record-breaking earnings report is being suppressed by market maker manipulation and option hedging, while many remain optimistic about a long-term rally toward double digits despite current price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vaxcyte Inc (PCVX) Is A Hidden Multibagger Stock To Buy Now

Vaxcyte Inc (PCVX) Is A Hidden Multibagger Stock To Buy Now...

Vaxcyte (NASDAQ:PCVX) Stock Price Down 6.8% - What's Next?

Vaxcyte (NASDAQ:PCVX) Stock Price Down 6.8% - Should You Sell...

Jennison Associates LLC Has $31.26 Million Stock Position in Vaxcyte, Inc. $PCVX

Jennison Associates LLC trimmed its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 42.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 677,553 shares of the company's stock after selling 493...

Vaxcyte (NASDAQ:PCVX) COO Sells $127,867.50 in Stock

Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) COO Jim Wassil sold 2,250 shares of the stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $56.83, for a total transaction of $127,867.50. Following the completion of the sale, the chief operating officer owned...

Universal Beteiligungs und Servicegesellschaft mbH Raises Stake in Vaxcyte, Inc. $PCVX

Universal Beteiligungs und Servicegesellschaft mbH boosted its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 105.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 70,124 shares of the company...

Pictet Asset Management Holding SA Has $40.67 Million Stock Position in Vaxcyte, Inc. $PCVX

Pictet Asset Management Holding SA reduced its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 14.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 881,435 shares of the company's stock after se...

Vaxcyte (NASDAQ:PCVX) Rating Lowered to Strong Sell at Wall Street Zen

Wall Street Zen downgraded shares of Vaxcyte from a "sell" rating to a "strong sell" rating in a report on Tuesday...

Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) have earned an average rating of "Moderate Buy" from the eight brokerages that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating and six have assig...

Vaxcyte (NASDAQ:PCVX) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded shares of Vaxcyte from a "strong sell" rating to a "sell" rating in a research report on Monday...

Vaxcyte (NASDAQ:PCVX) Stock Rating Lowered by Wall Street Zen

Wall Street Zen cut shares of Vaxcyte from a "sell" rating to a "strong sell" rating in a report on Sunday...

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Vaxcyte Inc

Bullish Sentiment

Rallies more than 5%

Modest gain (0-5%)

Modest decline (0-5%)

Drops more than 5%

Nvidia ($NVDA) reports earnings Wednesday, August 26, with options markets pricing in a roughly 5-7% post-earnings move. How do you think Nvidia's stock reacts to earnings? Vote and explain your reasoning in the comments.

Nvidia ($NVDA) reports earnings Wednesday, with options markets pricing in a 5-7% move. How do you think the stock reacts?

Stocktwits

) reports earnings Wednesday, with options markets pricing in a 5-7% move. How do you think the stock reacts?

Current Price	$61.09
Prev Close	$61.87
Open	$62.22
Dividend Yield	0.00%
50-Day Moving Average	$56.69
Beta	0.79
Avg. Volume	1.07M
PE Ratio	-7.92

52-Week High	$65.00
52-Week Low	$29.87
Market Capitalization	$9.21B
EPS (Annual)	-$5.63
Price to Book	3.21
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info